Watch out—momentum stocks are out of favor

Investing


Crispr Therapeutics AG: “Here’s the problem: that’s a momentum stock, and right now, momentum is out of favor so I cannot necessarily recommend that Crispr is the place to be.”

Camping World Holdings: “I think it trades with Thor, frankly, whether it should or not, and Thor hit another 52-week low today, so I am going to say not yet, not yet, not yet.”

Spectrum Pharmaceuticals: “No, man. If you’re going to do that, you want to go high end. I want you [in] Amgen, which my charitable trust owns. Amgen’s got this drug, Aimovig, which is taking the world by storm. It’s an anti-migraine drug. Amgen is the one you want.”

Avangrid Inc.: “All the utility stocks are going down. The two I’m recommending are Dominion now that it’s finishing up the South Carolina situation, but more importantly, AEP.”



Source link

Products You May Like

Articles You May Like

GE shares surge after analyst Sprague gives his first buy rating in a decade
JP Morgan faces lawsuits after guilty pleas by a former metals trader
Cramer talks sell-off, blesses some careful stock-picking
Treasury yields lower; Fed meeting in focus
Facebook, Google don’t allow CBD ads so ZenPup has to get creative

Leave a Reply

Your email address will not be published. Required fields are marked *